Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection

Key Points

• The aim is to assess adherence levels to DAA therapy in hepatitis C and identify factors affecting adherence.
• Analysis of treatment adherence data for DAA in hepatitis C
• Identification of clinical and non-clinical factors affecting adherence
• Development of potential interventions based on findings.
• Overall adherence to DAA therapy was found to be high among HCV patients.
• Several clinical and non-clinical factors contribute to non-adherence.
• Findings suggest a need for targeted interventions to improve adherence.

Abstract